CAS 755002-90-5

Fórmula: C20H31BrN2O2

InChI: InChI=1S/C20H31BrN2O2/c1-13(2)14-7-8-17(16(21)9-14)25-12-18(24)22-15-10-19(3,4)23-20(5,6)11-15/h7-9,13,15,23H,10-12H2,1-6H3,(H,22,24)

Clave InChI: OTTDLWFVHQYRDA-UHFFFAOYSA-N

SMILES: CC(C)C1=CC(=C(C=C1)OCC(=O)NC2CC(NC(C2)(C)C)(C)C)Br

2-(2-Bromo-4-isopropylphenoxy)-N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide

CAS: 755002-90-5

Fórmula: C₂₀H₃₁BrN₂O₂

Pureza: 98%

Forma y color: Solid

Peso molecular: 411.3763

Ref: IN-DA01LNCY

VU0134992

CAS: 755002-90-5

VU0134992

Fórmula: C₂₀H₃₁BrN₂O₂

Pureza: ≥98%

Peso molecular: 411.38

Ref: 54-BUP08912

VU0134992

CAS: 755002-90-5

VU0134992 is an Kir4.1 blocker with an IC50 value of 0.97 μM

Fórmula: C₂₀H₃₁BrN₂O₂

Pureza: 99.86%

Forma y color: Solid

Peso molecular: 411.376

Ref: TM-T8372

VU0134992

CAS: 755002-90-5

2-(2-Bromo-4-isopropylphenoxy)-N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide

Fórmula: C₂₀H₃₁BrN₂O₂

Pureza: 98%

Peso molecular: 411.38

Ref: IN-DG01056562

VU 0134992

CAS: 755002-90-5

VU 0134992 is a molecule that targets the epidermal growth factor receptor and has been shown to have antidepressant effects. VU 0134992 binds to the epidermal growth factor receptor and inhibits its tyrosine kinase activity, preventing phosphorylation of intracellular proteins. This inhibition leads to reduced cell proliferation and increased apoptosis, which may contribute to the effect of this drug as an antidepressant. VU 0134992 also blocks glutamate release from nerve terminals in the brain, which may be related to its antidepressant activity. The molecular modeling studies of this molecule suggest that it can bind to both monoamine oxidase A and B in order to prevent their enzymatic degradation of monoamines.

Fórmula: C₂₀H₃₁BrN₂O₂

Pureza: Min. 95%

Peso molecular: 411.38 g/mol

Ref: 3D-FFB00290